NovaFlow
AI for Clinic Operations
San Francisco, CA, USA
AI-powered bioinformatics analysis platform that transforms raw sequencing data into publication-ready analyses in minutes instead of weeks. It supports analytical domains including genomics, transcriptomics, and proteomics research, and handles various bioinformatics file types.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →How We Help
Problem Statement
Researchers spend weeks transforming raw sequencing data into publication-ready analyses.
Core Technology
AI-powered bioinformatics analysis platform
Key Differentiators
Transforms raw sequencing data into publication-ready analyses in minutes instead of weeks; Supports analytical domains including genomics, transcriptomics, and proteomics research; Supports data formats including CSVs, FASTQs, BAMs and other bioinformatics file types
Target Customers
General medical clinics and hospitals.
Product Stage
GA
Company Info
- Business Model
- B2B SaaS
- Founded
- 2025
- Total Funding
- 3,600,000
- Website
- www.novaflowapp.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
No peer-reviewed clinical studies or trials identified. Claims based on early adopter projections and internal metrics.
MedStartr Index Score
?What do you think of NovaFlow?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.